早期康复治疗联合依达拉奉对脑出血患者的疗效评价

Evaluation of Early Rehabilitation Therapy Combined With Edaravone for Patients With Cerebral Hemorrhage

目的探讨早期康复治疗联合依达拉奉对脑出血患者的临床疗效。方法抽取至我院2016年1月20日—2017年1月20日就诊的脑出血患者120例作为研究对象,依照入院时间的次序进行分组,每组均60例,其中对常规组单纯采取依达拉奉治疗,实验组在此基础上,给予早期康复治疗,对比两组患者的临床疗效。结果治疗前,两组NIHSS评分比较,差异无统计学意义(P>0.05);治疗4周与12周后,实验组NIHSS评分低于常规组,差异具有统计学意义(P<0.05)。治疗前,两组MMSE评分对比,差异无统计学意义(P>0.05);治疗4周与12周后,实验组MMSE评分高于常规组,差异具有统计学意义(P<0.05)。结论对脑出血患者采取早期康复治疗+依达拉奉的临床疗效显著,可明显改善患者的神经功能,改善预后,值得采纳。

Objective To explore the clinical efficacy of early rehabilitation therapy combined with the treatment of patients with cerebral hemorrhage. Methods 120 cases of cerebral hemorrhage were taken to our hospital from January 20, 2016 to January 20, 2017. They were divided into two groups according to the order of admission time, 60 cases in each group. The routine group was treated with edaravone alone. On this basis, the experimental group was given early rehabilitation treatment and compared the clinical efficacy of the two groups. Results Before treatment, there was no significant difference between the two groups of NIHSS scores（P〉 0.05）. After 4 weeks and 12 weeks of treatment, the NIHSS score of the experimental group was lower than that of the conventional group, and the difference was statistically significant（P 〈 0.05）. Before treatment, there was no significant difference between the two groups of MMSE scores（P 〉 0.05）. After 4 and 12 weeks of treatment, the MMSE score of the experimental group was higher than that of the conventional group, and the difference was statistically significant（P 〈 0.05）. Conclusion Early rehabilitation therapy for patients with cerebral hemorrhage and the clinical efficacy of etala are significant, which can obviously improve the patients’ neurological function and improve the prognosis.